Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PAVEL KLEIN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1770528648
CMS profile
216326
Location
BETHESDA, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$82,048.25

124 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 3; records 101–124 of 124 matching records. This page contains 24 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PAVEL KLEIN

NPI 1770528648 · CMS profile ID 216326

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

BETHESDA, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–124 of 124 matching records. This page contains 24 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1770528648?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PAVEL KLEIN, NPI 1770528648, CMS profile ID 216326. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–124 of 124 matching records. This page contains 24 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1770528648?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). PAVEL KLEIN, NPI 1770528648, CMS profile ID 216326. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–124 of 124 matching records. This page contains 24 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1770528648?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
PAVEL KLEIN, NPI 1770528648, CMS profile ID 216326, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–124 of 124 matching records. This page contains 24 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1770528648?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

124 matching records · $82,048.25 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 124 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–124 of 124.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
LivaNova USA, Inc. $20.3502/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043015337 CMS
Sumitomo Pharma America, Inc. $14.4202/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030879415 CMS
UCB, Inc. $36.0002/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021387145 CMS
UCB, Inc. $46.0002/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021387153 CMS
UCB, Inc. $48.0002/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021387163 CMS
UCB, Inc. $76.3402/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021387171 CMS
UCB, Inc. $322.9002/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021387177 CMS
UCB, Inc. $374.2002/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021387185 CMS
Sumitomo Pharma America, Inc. $8.6302/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030879427 CMS
UCB, Inc. $20.8902/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021400533 CMS
Lilly USA, LLC $21.3102/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032013017 CMS
Neurelis, Inc. $16.5102/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050921493 CMS
UCB, Inc. $16.9501/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021400515 CMS
UPSHER-SMITH LABORATORIES LLC $17.5401/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 994133645 CMS
Axsome Therapeutics, Inc. $20.8301/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056200799 CMS
SK Life Science, Inc. $54.6801/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054735849 CMS
SK Life Science, Inc. $50.0101/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054736573 CMS
SK Life Science, Inc. $60.0001/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054736583 CMS
SK Life Science, Inc. $20.9601/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054735829 CMS
SK Life Science, Inc. $65.0001/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054735837 CMS
SK Life Science, Inc. $166.8001/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054735843 CMS
Sumitomo Pharma America, Inc. $16.4401/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030879399 CMS
Celgene Corporation $16.4401/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015564331 CMS
ABBVIE INC. $26.3501/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997662527 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $150,603.15 307
PY2020 $156,884.29 172
PY2021 $119,686.79 163
PY2022 $124,057.45 198
PY2023 $82,048.25 124
PY2024 $38,421.60 50
PY2025 $37,154.42 31

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $89,657.97 23
PY2024 Recipient $1,975.00 1
PY2024 Principal investigator $270,329.90 89
PY2023 Recipient $420.00 1
PY2023 Principal investigator $365,143.97 97
PY2022 Recipient $6,400.00 2
PY2022 Principal investigator $170,649.28 25
PY2021 Recipient $17,120.00 3
PY2021 Principal investigator $724,237.07 94
PY2020 Recipient $12,880.00 13
PY2020 Principal investigator $635,503.64 63
PY2019 Recipient $45,044.91 9
PY2019 Principal investigator $279,662.75 22

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

23 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 SK Life Science, Inc. $9,891.87 12/01/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
YKP3089C025 No dispute reported 06/30/2026 1252274881
Principal investigator 1 SK Life Science, Inc. $2,147.89 11/12/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
YKP509C003 No dispute reported 06/30/2026 1252274841
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $2,915.00 10/20/2025 Non-covered Recipient Entity
WCG Clinical, Inc. WCG IRB, LLC
A Phase 1b, Multicenter, Open-Label, Single-arm Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) in Participants Aged 12 to 75 Years for the Treatment of Focal-Onset Seizures No dispute reported 06/30/2026 1233746314
Principal investigator 1 ABBVIE INC. $9,617.70 10/14/2025 Non-covered Recipient Entity
PAVEL KLEIN
A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures No dispute reported 06/30/2026 1202516741
Principal investigator 1 SK Life Science, Inc. $226.05 10/01/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
YKP509C003 No dispute reported 06/30/2026 1252274851
Principal investigator 1 SK Life Science, Inc. $4,227.96 08/22/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
YKP509C003 No dispute reported 06/30/2026 1252274831
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,317.60 07/09/2025 Non-covered Recipient Entity
MID ATLANTIC EPILEPSY AND SLEEP CENTER LLC
A STUDY OF SOTICLESTAT AS AN ADD-ON THERAPY IN CHILDREN AND ADULTS WITH DRAVET SYNDROME OR LENNOX-GASTAUT SYNDROME No dispute reported 06/30/2026 1223282490
Principal investigator 1 SK Life Science, Inc. $3,673.11 05/28/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
YKP509C003 No dispute reported 06/30/2026 1252274793
Principal investigator 1 SK Life Science, Inc. $564.68 05/28/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
YKP509C003 No dispute reported 06/30/2026 1252274797
Principal investigator 1 SK Life Science, Inc. $1,694.69 05/28/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
YKP509C003 No dispute reported 06/30/2026 1252274799
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $3,742.20 05/23/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND SLEEP CENTER
A STUDY OF SOTICLESTAT AS AN ADD-ON THERAPY IN CHILDREN AND ADULTS WITH DRAVET SYNDROME OR LENNOX-GASTAUT SYNDROME No dispute reported 06/30/2026 1223280286
Principal investigator 1 Immedica Pharma US, Inc. $2,527.54 04/29/2025 Non-covered Recipient Entity
MIDATLANTIC EPILEPSY & SLEEP
A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC) No dispute reported 06/30/2026 1225392411
Principal investigator 1 SK Life Science, Inc. $2,622.60 03/25/2025 Non-covered Recipient Entity
Mid-Atlantic Epilepsy & Sleep Center
YKP3089C040 No dispute reported 06/30/2026 1252274889
Principal investigator 1 SK Life Science, Inc. $12,102.03 03/25/2025 Non-covered Recipient Entity
Mid-Atlantic Epilepsy & Sleep Center
YKP3089C040 No dispute reported 06/30/2026 1252274891
Principal investigator 1 SK Life Science, Inc. $534.30 03/21/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
YKP509C003 No dispute reported 06/30/2026 1252274823
Principal investigator 1 SK Life Science, Inc. $1,717.98 03/21/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
YKP509C003 No dispute reported 06/30/2026 1252274825
Principal investigator 1 SK Life Science, Inc. $5,790.75 03/12/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
YKP509C003 No dispute reported 06/30/2026 1252274817
Principal investigator 1 SK Life Science, Inc. $2,664.90 03/11/2025 Non-covered Recipient Entity
Mid-Atlantic Epilepsy & Sleep Center
YKP3089C040 No dispute reported 06/30/2026 1252274887
Principal investigator 1 SK Life Science, Inc. $5,338.89 02/14/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
YKP509C003 No dispute reported 06/30/2026 1252274813
Principal investigator 1 Immedica Pharma US, Inc. $3,500.00 02/12/2025 Non-covered Recipient Entity
MIDATLANTIC EPILEPSY & SLEEP
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1225392323
Principal investigator 1 Immedica Pharma US, Inc. $8,500.00 02/12/2025 Non-covered Recipient Entity
MIDATLANTIC EPILEPSY & SLEEP
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1225392325
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,352.36 01/22/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
A STUDY OF SOTICLESTAT AS AN ADD-ON THERAPY IN CHILDREN AND ADULTS WITH DRAVET SYNDROME OR LENNOX-GASTAUT SYNDROME No dispute reported 06/30/2026 1223274327
Principal investigator 1 SK Life Science, Inc. $1,987.87 01/03/2025 Non-covered Recipient Entity
MID-ATLANTIC EPILEPSY AND
YKP509C003 No dispute reported 06/30/2026 1252274821